U.S. Transportation Stock News

The market seemed underwhelmed by the solid earnings posted by Accenture plc ( NYSE:ACN ) recently. Along with the...

Lifecore Biomedical, Inc. ( NASDAQ:LFCR ), is not the largest company out there, but it received a lot of attention...

The FIRE movement is moving from niche message boards to mainstream headlines, and that shift is starting to shape how money flows into investment platforms and asset managers. As more people pursue early financial independence, some companies could see stronger demand for low-cost investing tools, while others face pressure from extreme frugality and stretched household budgets. This article examines how the FIRE trend intersects with the Investment Platforms & Asset Managers screener and...

The Morning Bull - US Market Morning Update Tuesday, Jun, 30 2026 US stock futures are pointing higher this morning, with benchmark S&P 500 contracts up about 0.7% and Nasdaq-100 futures up roughly 1.1%, as investors balance mixed economic signals. The US goods trade deficit widened to $105.8b in May 2026 because imports grew while exports fell, which hints at solid domestic demand but softer overseas sales for US companies. The Michigan Consumer Sentiment index was revised to 49.5, a level...

What Stepan’s Russell 2000 Dynamic Index Addition Means for Investors Stepan (SCL) has been added to the Russell 2000 Dynamic Index, a move that often prompts portfolio adjustments by index trackers and some institutional investors. This change is putting fresh attention on the stock’s recent performance and fundamentals. See our latest analysis for Stepan. Beyond the index news, Stepan’s share price has recently been supported by a 15.88% year to date share price return and a 9.34% 90 day...

Equitable Holdings, Inc. (NYSE: EQH) was recently added to several Russell Value indices, including the Russell 1000, 2500, 3000, 3000E, Small Cap Comp, and Midcap Value Benchmarks, increasing its presence across a wide range of value-focused benchmarks. This broad index inclusion can influence how institutional investors view Equitable Holdings in diversified value portfolios, as index-tracking and benchmark-aware funds often adjust holdings to reflect such changes. We will now examine how...

In late June 2026, Roivant Sciences Ltd. was removed from both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, reflecting changes in these benchmarks’ constituent lists. This dual index removal highlights how shifts in passive investment flows and institutional portfolio construction can influence how a biopharmaceutical company is perceived in the market. We’ll now examine how Roivant’s removal from key Russell defensive indices may affect its existing...

Genco Shipping & Trading (GNK) has recently drawn investor attention after a fresh look at its valuation metrics, with the stock last closing at $24.39 and carrying a value score of 2. See our latest analysis for Genco Shipping & Trading. Over the past year, Genco Shipping & Trading’s share price has built clear positive momentum, with a year to date share price return of 32.27% and a 1 year total shareholder return of 97.15%. Longer term total shareholder returns over 3 and 5 years of...

Why Marcus & Millichap Stock Is on Investors’ Radar Marcus & Millichap (MMI) has drawn fresh attention after recent trading left the stock with a roughly 10% gain over the past month and about 17% over the past 3 months. See our latest analysis for Marcus & Millichap. Against a latest share price of $31.21, Marcus & Millichap’s 7 day share price return of 8.33% and 90 day share price return of 17.38% contrast with a 1 year total shareholder return of 3.41% and 5 year total shareholder return...

Payoneer Global (PAYO) was recently added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, an inclusion that can influence index-tracking fund flows, trading activity, and overall investor attention. See our latest analysis for Payoneer Global. That index inclusion comes after a period of strong momentum for Payoneer Global, with the share price delivering a 30-day return of 36.35% and a 90-day return of 46.79%. The 3-year total shareholder return stands...

Cross-border Chinese wealth management and brokerage stocks are suddenly under a harsh spotlight after the sentencing of tycoon Guo Wengui in the US for a billion-dollar fraud scheme. For you as an investor, this kind of shock can reshape how regulators, clients, and counterparties view risk around Chinese capital flows and financial platforms. This article explains how that shift may affect a handful of Chinese Wealth Management and Brokerage Stocks With Regulatory Exposure, and walks...

China’s latest PMI data points to a cautiously stabilising economy, with global demand for high-tech exports, AI hardware, and renewable equipment helping to offset weak local spending and a sluggish property sector. For investors, that combination of export strength and selective industrial profit growth creates a focused opportunity set, as some companies are more directly exposed to these cross-border AI and high-tech trends than others. This article breaks down 3 stocks from our AI and...

Middleby’s food processing spin-off, Midera Food Processing, Inc., previously entered a five-year, US$1.0 billion credit agreement with Bank of America and other lenders, comprising a US$750 million U.S. revolving facility and a US$250 million multi-currency revolving facility, with the separation targeted for completion on July 6, 2026, subject to conditions. This substantial financing package signals that Midera will launch as a stand-alone business with significant liquidity and capital...

Afya (NasdaqGS:AFYA) is back in focus after recent share performance, with the stock flat over the past day but up over the past week and month, prompting closer attention to its valuation and fundamentals. See our latest analysis for Afya. Over the past month Afya has shown improving momentum, with a 1 month share price return of 6.14% contrasting with a year to date share price return that is slightly down and a 1 year total shareholder return that has also declined. If you are comparing...

Recently, analyst commentary highlighted that Ubiquiti Inc. is expected to benefit from trends such as IoT proliferation, fiber densification, and 5G adoption, with earnings estimates revised upward despite persistent price competition and elevated raw material costs. This combination of rising earnings expectations and exposure to long-term network infrastructure themes has reinforced optimism about Ubiquiti’s business outlook across both emerging and developed markets. Next, we’ll examine...

Array Technologies (ARRY) is drawing attention after launching its DuraTrack D2S dual row solar tracker for international markets, with the first commercial installation already underway in Spain in early 2026. See our latest analysis for Array Technologies. Even with the DuraTrack D2S launch and a new shelf registration filing, Array Technologies’ share price has come under pressure, with the 30 day share price return down 21.59% and the 1 year total shareholder return still positive at...

Arbor Realty Trust, Inc. was recently removed from the Russell 2000 Dynamic Index, a move that typically prompts portfolio adjustments by index-tracking funds. This index exit may influence how investors view Arbor Realty Trust’s liquidity and visibility relative to other small-cap real estate finance names. We’ll now examine how Arbor Realty Trust’s removal from the Russell 2000 Dynamic Index could reshape its existing investment narrative. We've uncovered the 9 dividend fortresses yielding...

In late June 2026, MFA Financial, Inc. was added to multiple Russell benchmarks, including the Russell 2000 Growth-Defensive, Russell 2500 Growth, Russell 3000 Growth, Russell 3000E Growth, and the Russell Small Cap Comp Growth indices. This broad inclusion across Russell growth and small-cap indices significantly broadens MFA Financial’s presence in benchmark-driven portfolios, potentially increasing attention from institutional and rules-based investors. Now we’ll examine how MFA...

BrightView Holdings (BV) has moved to extend the maturity of its senior secured term loans from April 2029 to June 2033, and is also lengthening its receivables financing facility to June 2029. See our latest analysis for BrightView Holdings. BrightView Holdings’ recent debt maturity extensions come as the stock trades at $14.27, with a 30-day share price return of 15.45% and a 90-day share price return of 21.03%, yet a 1-year total shareholder return that declined 14.29%. This suggests...

On 27 June 2026, Brixmor Property Group Inc. was removed from the Russell 1000 Dynamic Index, prompting index-tracking funds to adjust their positions. This index removal matters because forced buying and selling by rules-based investors can reshape who owns the stock and how it trades over time. With Brixmor’s exit from the Russell 1000 Dynamic Index now in the past, we’ll explore how this change may influence its investment narrative. The best AI stocks today may lie beyond giants like...

Index removals put TIC Solutions in the spotlight TIC Solutions (TIC) has been removed from several Russell indices, including the Russell 2000, 3000, and 2500 growth and defensive benchmarks. This change can influence both trading flows and investor attention. See our latest analysis for TIC Solutions. TIC Solutions has seen mixed momentum, with the share price up 25.99% over the past 90 days but the year to date share price return down 16.18%, and the 1 year total shareholder return down...

The FDA’s new PreCheck pilot is putting fresh attention on U.S. biopharmaceutical manufacturing stocks, as faster facility reviews could reshape how quickly companies bring complex therapies to market. With select facilities from Eli Lilly, Regeneron and others lined up for accelerated oversight, investors are watching which businesses might gain from quicker approvals, added capacity and stronger onshore supply chains, and which could be left waiting. This article walks through 3 stocks from...

Why the QUELL-CV Trial Matters for BioAge Labs Stock BioAge Labs (BIOA) has moved its lead drug candidate, BGE-102, into the Phase 2 QUELL-CV trial, a randomized, placebo-controlled study targeting cardiovascular risk in adults with obesity and elevated inflammation. The trial plans to enroll about 160 participants over 12 weeks of once daily dosing, testing three oral dose levels against placebo. The primary focus is change in high-sensitivity C-reactive protein, with additional inflammatory...

Recently, Savara announced that the US FDA accepted its biologics license application for MOLBREEVI for autoimmune pulmonary alveolar proteinosis, assigning a PDUFA target action date of November 22, while CFO David Lowrance exercised 580,187 stock options and sold 394,528 shares. This regulatory milestone and executive share activity highlight both the advancing path toward a potential first-in-class therapy and how insiders are managing their equity exposure at a key moment for the...